Literature DB >> 30415231

Early detection of lung cancer in a population at high risk due to occupation and smoking.

Laura S Welch1, John M Dement2, Kim Cranford3, Janet Shorter3, Patricia S Quinn1, David K Madtes4,5, Knut Ringen1.   

Abstract

OBJECTIVE: The US National Comprehensive Cancer Network (NCCN) recommends two pathways for eligibility for Early Lung Cancer Detection (ELCD) programmes. Option 2 includes individuals with occupational exposures to lung carcinogens, in combination with a lesser requirement on smoking. Our objective was to determine if this algorithm resulted in a similar prevalence of lung cancer as has been found using smoking risk alone, and if so to present an approach for lung cancer screening in high-risk worker populations.
METHODS: We enrolled 1260 former workers meeting NCCN criteria, with modifications to account for occupational exposures in an ELCD programme.
RESULTS: At baseline, 1.6% had a lung cancer diagnosed, a rate similar to the National Lung Cancer Screening Trial (NLST). Among NLST participants, 59% were current smokers at the time of baseline scan or had quit smoking fewer than 15 years prior to baseline; all had a minimum of 30 pack-years of smoking. Among our population, only 24.5% were current smokers and 40.1% of our participants had smoked fewer than 30 pack-years; only 43.5% would meet entry criteria for the NLST. The most likely explanation for the high prevalence of screen-detected lung cancers in the face of a reduced risk from smoking is the addition of occupational risk factors for lung cancer.
CONCLUSION: Occupational exposures to lung carcinogens should be incorporated into criteria used for ELCD programmes, using the algorithm developed by NCCN or with an individualised risk assessment; current risk assessment tools can be modified to incorporate occupational risk. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  construction; exposures and occupational groups; materials; methodology; speciality

Mesh:

Substances:

Year:  2018        PMID: 30415231     DOI: 10.1136/oemed-2018-105431

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  7 in total

1.  Lung cancer screening in patients with Libby amphibole disease: High yield despite predominantly environmental and household exposure.

Authors:  Gregory Loewen; Brad Black; Tracy McNew; Albert Miller
Journal:  Am J Ind Med       Date:  2019-09-18       Impact factor: 2.214

2.  Cost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects.

Authors:  Sébastien Gendarme; Jean-Claude Pairon; Pascal Andujar; François Laurent; Patrick Brochard; Fleur Delva; Bénédicte Clin; Antoine Gislard; Christophe Paris; Isabelle Thaon; Helene Goussault; Florence Canoui-Poitrine; Christos Chouaïd
Journal:  Cancers (Basel)       Date:  2022-08-24       Impact factor: 6.575

3.  Risk for lung-related diseases associated with welding fumes in an occupational population: Evidence from a Cox model.

Authors:  Guangming Li; Jinfeng Jiang; Yonggang Liao; Siyu Wan; Yong Yao; Yongbin Luo; Xuyu Chen; Huiling Qian; Xiayun Dai; Wenjun Yin; Zhiteng Min; Guilin Yi; Xiaodong Tan
Journal:  Front Public Health       Date:  2022-08-25

4.  Are there social gradients in the occurrence of lung cancer and in the survival of lung cancer patients? Findings from an observational study using German claims data of Lower Saxony.

Authors:  Sebastian Schröder; Johannes Beller; Heiko Golpon; Siegfried Geyer
Journal:  BMJ Open       Date:  2020-09-02       Impact factor: 2.692

Review 5.  Lung Cancer Screening in Asbestos-Exposed Populations.

Authors:  Steven B Markowitz
Journal:  Int J Environ Res Public Health       Date:  2022-02-25       Impact factor: 3.390

6.  Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410

7.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.